Ultomiris has met its primary endpoint in a phase III trial targeting immunoglobulin A nephropathy (IgAN), a rare ...

Positive high-level results from a prespecified interim analysis of the I CAN Phase III trial showed that Ultomiris (ravulizumab) met its primary ...

President and CEO Doug Love outlined a series of anticipated clinical and regulatory milestones during the 25th Annual ...

Vector-10 is a registered trademark and patented technology of Vera Clinic. All clinical data collected under institutional ...

Certainly, cravings can get the best of us and in some cases too much of what we crave can result in some unhealthy outcomes.

ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease ...

NAB believes that with GPS increasingly recognized as a potential single point of failure, BPS has an important role to play.

Your home is a treasure chest of items that, with a little creativity, can find a new purpose in your backyard. Before you ...

Firms like Function Health and Oura market regular blood tests to people wanting to take their health into their own hands.

GE moved to walk away from Vineyard Wind contracts. The developer went to court. What did the judge call 'fanciful'?

As enterprises race to deploy autonomous AI agents, a growing concern has emerged around what these agents are permitted to ...

Olverembatinib, an investigational multikinase inhibitor (approved in China for CML), inhibits Src-family kinases (e.g., Lyn, ...